Full Press Release Details
| Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507 | ||
| Tel | :+91 40 4900 2900 | |
| Fax | :+91 40 4900 2999 | |
| :mail@drreddys.com | ||
| www.drreddys.com |
| Corporate Relationship Department | National Stock Exchange of India Ltd. |
| BSE Limited | "Exchange Plaza" |
| Dalal Street, Fort | Bandra-Kurla Complex, Bandra (East), |
| Mumbai - 400 001 | Mumbai - 400 051 |
| Fax Nos.: 022-22723121 / 22723719 | Fax Nos.: 022-26598120/ 26598237 |
| Scrip Code: 500124 | Scrip Code: DRREDDY-EQ |
This is to inform you that the audit of
our API Manufacturing Plant 2 at Bollaram, Hyderabad by the US FDA, has been completed today. We have been issued a Form 483 with
5 observations. We will address them comprehensively within the stipulated timeline.
This is for your information.
| /s/ Sandeep Poddar | |
| Sandeep Poddar | |
| Company Secretary |
CC:- New York Stock Exchange Inc.(Stock Code :RDY)